A decade-long study which is a part of the German Ablation Registry highlighted the long-term outcomes of catheter ablation, ...

The new name draws from the company’s nearly two decades of work in ryanodine receptor (RyR) biology, which it has used to ...

With dropping temperatures in many parts of the country, the general public is reminded of the accompanying risk of heart ...

Using computers to make a digital replica of the heart—a digital heart twin—can successfully identify problem areas deep in ...

BACKGROUND: Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high ...

Heart palpitations generally increase while pregnant because the heart works overtime as the fetus grows. Learn how to keep ...

A 68-year-old woman in Hyderabad survived multiple cardiac arrests with advanced treatment at Care Hospitals. Read about her ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, is proud to announce key milestones ...

Clinical Electrophysiology journal showed that when acute procedural success is attained in a subset of patients with ...

Catheter ablation is the primary treatment option for idiopathic ventricular tachycardia (VT). It plays a key role in acute therapy of electrical storm, treatment of VTs in patients with structural ...

Droperidol was a first-line, highly effective agent for the treatment of PONV for over 30 years. It has the most postmarketing surveillance data of any of the currently used antiemetic agents.

Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by high risks of sustained ventricular tachycardia (sVT) and sudden cardiac death. Identifying patients ...